Peptides in the pipeline: How companies are overcoming the early-stage challenges
In a pharmaceutical world so often divided by molecules large or small, peptides have struggled to find their place. Fortunately, an identity crisis has not stopped this unique drug class from cementing its status as one of the most important pharmaceutical breakthroughs of all time.
